http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
만성 폐쇄성 폐질환 환자에서 수면중 저산소혈증의 예측지표
최기원(Ki Won Choi),김혜영(Hye Young Kim),박남규(Nam Gyu Park),곽남주(Nam Ju Kwak),오태근(Tae Geun Oh),김동운(Dong Woon Kim),김승택(Seung Taik Kim),이상도(Sang Do Lee) 대한내과학회 1996 대한내과학회지 Vol.51 No.4
Objectives: In chronic obstructive pulmonary disease, nocturnal hypoxemia is associated with pulmonary hypertension, arrhythmia and increased mortality during sleep. So a noninvasive, inexpensive method of predicting significant sleep-associated nocturnal hypoxemia would be desirable for patients being investigated and treated for chronic obstructive pulmonary disease. This study was performed to identify the incidence and accurate predictive indicators for nocturnal hypoxemia in these patients. Methods: We measured nocturnal SaO2 during sleep and overnight change of urinary uric acid/creatinine ratio and performed daytime arterial blood gas analysis and pulmonary function test in twenty-eight patients with chronic obstructive pulmonary disease. Results: 1) Nocturnal hypoxemia occurred in 12 of 28 COPD patients (43%), 9 of 13 blue-bloaters (70%) and 3 of 15 pink-puffers (20%). The incidence of nocturnal hypoxemia was higher in blue-bloaters than pink-puffers (p<0.05). 2) Daytime PaO2 was lower and PaCO2 was higher in hypoxemia group than those of normoxemia group (p<0.05). 3) There was significant correlation between daytime PaO2 and nocturnal lowest SaO2 in hypoxemia group (r=0.72, p<0.05). 4) There were no correlations between daytime PaO2 and nocturnal mean SaO2 and between daytime PaCO2 and lowest or mean nocturnal SaO2 in hypoxemia group. 5) Overnight change of urinary uric acid/creatinine ratio was not significantly different between hypoxemic and normoxemic group. 6) There was no significant difference in pulmonary function test values between hypoxemic and normoxemic group. Conclusion: These data indicate that daytime PaO2 is an useful indicator to predict nocturnal hypoxemia in chronic obstructive pulmonary disease but overnight change of urinary uric acid excretion is not.
김혜영(Hye Young Kim),조명찬(Myeong Chan Cho),최기원(Ki Won Choi),박남규(Nam Kyu Park),곽남주(Nam Ju Kwak),박국태(Kuck Tae Park),엄재호(Jae Ho Earm),윤세진(Sei Jin Youn),이복희(Bok Hee Lee) 대한소화기학회 1996 대한소화기학회지 Vol.28 No.2
N/A Background: A new tumor marker, TAG-72 has been identified using monoclonal antibody B72.3. It is found in a wide variety of carcinomas but rarely expressed in normal adult tissue.', and benign lesions. Methods: The presence of TAG-72 in serum samples from patients with gastric carcinoma and benign gastrointestina1 disease was evaluated using the CA72-4 assay. Results: Elevated levels of serum TAG-7'2 antigen were found in 2S(39. I io) of 64 gastric carcinona patients and none of 32 benign gastrointestinal disease patients. The serum concentrations of TAG-72 were compared to those of CEA. The positive rate of CEA in gastric carcinoma and benign gastrointestinal disease patients was 37.5% and 9.4%, respectively. These resu]ts indicate a preferential expression of TAG-72 compared to CEA in gastric carcinoma patients versus in patients with a benign disorder. Combination assay using CA72-4 and CEA RIAs unchanged positive rate(50%, p>0.05). Patients with the tnore advanced stage of gastric carcinoma revealed the higher positive rate of serum CA72-4 and the ]evels were increased in all patients with recurrent gastric carcinoma. ( onclusions: These results suggest that the measurement of serum CA72-4 in patients with gastric carcinoma serve a complementary role to differentiate the disease from benign gastric lesions and may be useful to predict the disease recurrence in postoperative patients. (Korean J Gastroenterol 1996; 28:164 171)
김혜영,박남규,윤세진,최기원,엄재호,이복희,조명찬,박국태,곽남주 대한소화기학회 1996 대한소화기학회지 Vol.28 No.4
Background: A new tumor marker, TAG-72 has been identified using monoclona] antibody B72.3. It is found in a wide variety of carcinomas but rarely expressed in normal adult tissue and benign lesions. Methods: The presence of TAG-72 in serum samples from patients with gastric carcinoma and benign gastrointestinal disease has been evaluated using the CA72-4 assay. Results: Elevated levels of serum TAG-72 antigen were found in 25(39.1%) of 64 gastric carcinoma patients and none of 32 benign gastrointestinal disease patients. The serum concentrations of TAG-72 were compared to those of CEA. The positive rate of CEA in gastric carcinoma and benign gastroin- testinal disease patients were 37.5% and 9.4%, respectively. These results indicate a preferential expression of TAG-72 compared to CEA in gastric carcinoma patients versus in patients with benign disorder. Combinatinn assay using CA72-4 and CEA RIAs unchanged positive rate(50%, p$gt;0.05). In patients with the more advanced stage of gastric carcinoma revealed the higher positive rate of serum CA72-4 and the levels were increased in all patients with recurrent gastric carcinomo. Conclusions: These results suggest that the measurement of serum CA72-4 in patients with gas1ric carcinoma serve as a complementary role to differentiate the disease from benign gastric lesions and may be useful to predict tbe disease recurrence in postoperative patients.